Deferred Tax Assets, Valuation Allowance of Evoke Pharma Inc from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Evoke Pharma Inc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Evoke Pharma Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $28,230,000, a 2.4% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Evoke Pharma Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $28,230,000 -$709,000 -2.4% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $28,939,000 +$26,853,000 +1287% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $2,086,000 +$20,000 +0.97% 31 Dec 2022 10-K/A 14 May 2024 2023 FY
Q4 2021 $2,066,000 -$376,000 -15% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q4 2020 $2,442,000 +$1,279,000 +110% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q4 2019 $1,163,000 +$264,000 +29% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $899,000 +$90,000 +11% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 $809,000 -$61,000 -7% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $870,000 +$40,000 +4.8% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q4 2015 $830,000 +$185,000 +29% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $645,000 +$208,000 +48% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q4 2013 $437,000 +$70,000 +19% 31 Dec 2013 10-K 04 Mar 2015 2014 FY
Q4 2012 $367,000 31 Dec 2012 10-K 25 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.